Envoy Medical, Inc. (COCH) Insider Trading Activity

NASDAQ$7.175+0.55 (8.31%)
Market Cap
$51.24M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
52 of 849
Rank in Industry
6 of 107

COCH Insider Trading Activity

COCH Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$8,173,460
6
100
Sells
$0
0
0

Related Transactions

TAYLOR GLEN A10 percent owner
1
$7.5M
0
$0
$7.5M
BRYNELSEN CHARLESdirector
1
$400,000
0
$0
$400,000
Patel Mona Chetandirector
1
$125,000
0
$0
$125,000
Potashnick RobertInterim CFO
1
$85,000
0
$0
$85,000
Kantor Susandirector
1
$38,460
0
$0
$38,460
Lucas Brent T.Chief Executive Officer
1
$25,000
0
$0
$25,000

About Envoy Medical, Inc.

Envoy Medical, Inc. is a healthcare company dedicated to developing innovative medical technologies that address the full spectrum of hearing loss. Its diverse product portfolio includes conventional hearing aids, Esteem middle ear implants, bone conduction devices, and Acclaim cochlear implants. Established in 1995, the company originally operated as St. Croix Medical, Inc. before officially rebranding to Envoy Medical, Inc. in December 2004. Envoy Medical, Inc. is headquartered in White Bear Lake, Minnesota.

Insider Activity of Envoy Medical, Inc.

Over the last 12 months, insiders at Envoy Medical, Inc. have bought $8.17M and sold $0 worth of Envoy Medical, Inc. stock.

On average, over the past 5 years, insiders at Envoy Medical, Inc. have bought $5.24M and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: TAYLOR GLEN A (10 percent owner) — $7.5M. BRYNELSEN CHARLES (director) — $400,000. Patel Mona Chetan (director) — $125,000.

The last purchase of 18,750,000 shares for transaction amount of $7.5M was made by TAYLOR GLEN A (10 percent owner) on 2026‑02‑12.

List of Insider Buy and Sell Transactions, Envoy Medical, Inc.

2026-02-12PurchaseTAYLOR GLEN A10 percent owner
18.75M
65.8107%
$0.40
$7.5M
+31.68%
2026-02-12PurchaseBRYNELSEN CHARLESdirector
1M
3.5099%
$0.40
$400,000
+31.68%
2026-02-12PurchasePatel Mona Chetandirector
312,500
1.0968%
$0.40
$125,000
+31.68%
2026-02-12PurchaseLucas Brent T.Chief Executive Officer
62,500
0.2194%
$0.40
$25,000
+31.68%
2026-02-12PurchasePotashnick RobertInterim CFO
212,500
0.7459%
$0.40
$85,000
+31.68%
2026-02-12PurchaseKantor Susandirector
96,150
0.3375%
$0.40
$38,460
+31.68%
2025-06-11PurchasePatel Mona Chetandirector
2,500
0.0119%
$1.47
$3,675
-48.34%
2025-06-06PurchasePatel Mona Chetandirector
10,000
0.0449%
$1.46
$14,600
-50.72%
2025-05-27PurchaseBRYNELSEN CHARLESdirector
35,000
0.1734%
$1.65
$57,673
-50.26%
2025-05-23PurchaseBRYNELSEN CHARLESdirector
13,000
0.0615%
$1.64
$21,363
-52.30%
2025-05-22PurchaseBRYNELSEN CHARLESdirector
2,000
0.0095%
$1.68
$3,367
-53.35%
2024-11-20PurchasePatel Mona Chetandirector
2,500
0.0123%
$2.28
$5,699
-33.02%
2024-09-11PurchasePatel Mona Chetandirector
4,000
0.0289%
$3.33
$13,320
-51.89%
2024-09-09PurchasePatel Mona Chetandirector
1,000
0.0069%
$3.20
$3,200
-52.92%
2023-11-21PurchaseLucas Brent T.Chief Executive Officer
12,380
0.026%
$0.97
$11,990
+158.76%
2023-11-20PurchaseTAYLOR GLEN A
100,000
–
$11.50
$1.15M
+151.00%
2023-09-29PurchaseAnzu SPAC GP I LLC10 percent owner
1M
–
$11.50
$11.5M
-66.17%
Total: 17
*Gray background shows transactions not older than one year
*Some uncertain data for Preferred Stock share type transactions are shown in italics; for actual data please follow the link

Insider Historical Profitability

<0.0001%
TAYLOR GLEN A10 percent owner
21703607
280.428%
$143.68M20
+151%
BRYNELSEN CHARLESdirector
1050000
13.5668%
$6.95M40
<0.0001%
Patel Mona Chetandirector
332500
4.2962%
$2.2M60
<0.0001%
Lucas Brent T.Chief Executive Officer
297090
3.8386%
$1.97M20
+158.76%
Potashnick RobertInterim CFO
212500
2.7457%
$1.41M10
Kantor Susandirector
174037
2.2487%
$1.15M10
Anzu SPAC GP I LLC10 percent owner
1000000
12.9208%
$6.62M10
<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$9,837,727
35
7.68%
$94.71M
$1,105,104
34
-11.40%
$311.25M
$20,867,362
27
-3.90%
$467.11M
$58,749,198
24
16.21%
$100.45M
$842,771
15
6.44%
$214.28M

COCH Institutional Investors: Active Positions

Increased Positions13+37.14%356,491+16.5%
Decreased Positions13-37.14%1M-49.29%
New Positions6New256,209New
Sold Out Positions8Sold Out1MSold Out
Total Postitions350%1M-32.79%

COCH Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Atlas Merchant Capital Llc$387.001.92%555,52700%2025-09-30
Vanguard Group Inc$236.001.17%339,110-55,851-14.14%2025-09-30
Weiss Asset Management Lp$169.000.84%242,639-125,505-34.09%2025-09-30
Focus Partners Wealth$148.000.73%212,65500%2025-09-30
Dsg Capital Advisors, Llc$114.000.56%163,64200%2025-09-30
Arcus Capital Partners, Llc$106.000.53%152,868-34,705-18.5%2025-09-30
Cibc Private Wealth Group Llc$54.000.27%77,88700%2025-09-30
Morgan Stanley$39.000.2%56,500+5,559+10.91%2025-09-30
Geode Capital Management, Llc$32.000.16%46,538-47,593-50.56%2025-09-30
Highpoint Advisor Group Llc$27.000.13%38,66200%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.